Filter By:

Journal Check one or more journals to show results from those journals only.

Choose more journals

Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–2 of 2 results
Advanced filters: Author: Shadi A. Esfahani Clear advanced filters
  • This Case Study discusses the management of a female neonate in whom a large pelvic mass had been detected 9 weeks before birth. She was diagnosed with botryoid rhabdomyosarcoma of the bladder. Tumor eradication was achieved with chemotherapy alone, and she remained free from recurrence during 24 months of follow-up.

    • Shadi Abdar Esfahani
    • Laleh Montaser-Kouhsari
    • Abdol-Mohammad Kajbafzadeh
    Reviews
    Nature Reviews Urology
    Volume: 6, P: 449-453
  • Lorlatinib—a ROS1/ALK inhibitor—is currently undergoing clinical trials for the treatment of non-small cell lung cancers. Here the authors develop synthetic routes to11C- and 18F-labelled lorlatinib, with subsequent PET imaging showing good blood brain barrier permeability in non-human primates.

    • Thomas Lee Collier
    • Marc D. Normandin
    • Neil Vasdev
    ResearchOpen Access
    Nature Communications
    Volume: 8, P: 1-12